No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs113831576 |
chr2:30522765-30522766 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs556771953 |
chr2:30522791-30522792 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs577143497 |
chr2:30522822-30522823 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs11678328 |
chr2:30522830-30522831 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs116135281 |
chr2:30522887-30522888 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs114768311 |
chr2:30522918-30522919 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs541719849 |
chr2:30522919-30522920 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs562119165 |
chr2:30523003-30523004 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs145289404 |
chr2:30523012-30523013 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs530806352 |
chr2:30523017-30523018 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs529323313 |
chr2:30523021-30523022 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs200644403 |
chr2:30523024-30523025 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs374523579 |
chr2:30523076-30523077 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs368518107 |
chr2:30523082-30523083 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs551093291 |
chr2:30523197-30523198 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs570592993 |
chr2:30523221-30523222 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs533373628 |
chr2:30523222-30523223 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs546811069 |
chr2:30523293-30523294 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs566689360 |
chr2:30523298-30523299 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs56069415 |
chr2:30523312-30523313 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs535754271 |
chr2:30523327-30523328 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs138755844 |
chr2:30523341-30523342 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs141864365 |
chr2:30523367-30523368 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs527891534 |
chr2:30523399-30523400 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs191572528 |
chr2:30523400-30523401 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs146046245 |
chr2:30523441-30523442 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs568827131 |
chr2:30523497-30523498 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs139691361 |
chr2:30523498-30523499 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs148304747 |
chr2:30523525-30523526 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs539508749 |
chr2:30523530-30523531 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs553216088 |
chr2:30523593-30523594 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs573029322 |
chr2:30523612-30523613 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs542152044 |
chr2:30523654-30523655 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs141450793 |
chr2:30523679-30523680 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs150847284 |
chr2:30523682-30523683 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs544255042 |
chr2:30523705-30523706 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs564110962 |
chr2:30523722-30523723 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs533266169 |
chr2:30523758-30523759 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs12104948 |
chr2:30523804-30523805 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs560315981 |
chr2:30523819-30523820 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs11127265 |
chr2:30523848-30523849 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs77749089 |
chr2:30523863-30523864 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs539923075 |
chr2:30523881-30523882 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs12104953 |
chr2:30523920-30523921 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs538502610 |
chr2:30523942-30523943 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs550613810 |
chr2:30523946-30523947 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs139321048 |
chr2:30523983-30523984 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs570424570 |
chr2:30524017-30524018 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs145550652 |
chr2:30524018-30524019 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs183431768 |
chr2:30524083-30524084 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|